Serve Robotics (NASDAQ: SERV) details 2026 meeting, director votes and PwC ratification
Serve Robotics Inc. is asking stockholders to vote at its 2026 virtual annual meeting on June 17, 2026. The main items are electing two Class III directors, Ali Kashani and Touraj Parang, to terms running to 2029, and ratifying PwC as independent auditor for 2026.
The record date is April 20, 2026, with 77,324,755 common shares outstanding. Serve highlights its sidewalk delivery robot fleet of over 2,000 units, integrations with platforms such as Uber Eats and DoorDash, and its January 2026 acquisition of Diligent Robotics to expand into indoor healthcare robotics.
Positive
- None.
Negative
- None.
Key Figures
Key Terms
emerging growth company regulatory
Rule 10b5-1 Trading Plan Policy regulatory
broker non-votes regulatory
change in control financial
Compensation Recovery Policy regulatory
equity incentive plan financial
Compensation Summary
| Name | Title | Total Compensation |
|---|---|---|
| Ali Kashani | ||
| Touraj Parang | ||
| Brian Read |
- Election of two Class III directors (Ali Kashani and Touraj Parang) until 2029
- Ratification of PwC as independent registered public accounting firm for fiscal year ending December 31, 2026
TABLE OF CONTENTS
☐ | Preliminary Proxy Statement |
☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
☒ | Definitive Proxy Statement |
☐ | Definitive Additional Materials |
☐ | Soliciting Material Pursuant to §240.14a-11(c) or §240.14a-2 |
☒ | No fee required. |
☐ | Fee paid previously with preliminary materials. |
☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
TABLE OF CONTENTS
1. | To elect the two nominees to serve as Class III directors until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified; |
2. | To ratify the appointment of PricewaterhouseCoopers LLP (“PwC”) as our independent registered public accounting firm for our fiscal year ending December 31, 2026; and |
3. | To transact such other business as may properly come before the Annual Meeting or any postponements, adjournments or continuations thereof. |
TABLE OF CONTENTS
2026 ANNUAL MEETING OF STOCKHOLDERS | 1 | ||
FREQUENTLY ASKED QUESTIONS | 2 | ||
BOARD OF DIRECTORS AND CORPORATE GOVERNANCE | 8 | ||
Director Independence | 8 | ||
Board Leadership Structure | 8 | ||
Board Meetings and Attendance | 8 | ||
Committees of the Board of Directors | 9 | ||
Role of the Board of Directors in Risk Oversight | 11 | ||
Considerations in Evaluating Director Nominees | 11 | ||
Stockholder Recommendations for Nominations to the Board of Directors | 11 | ||
Communications with the Board of Directors | 12 | ||
Corporate Governance Guidelines and Code of Business Conduct and Ethics | 12 | ||
Insider Trading Policy and Anti-Hedging | 12 | ||
Rule 10b5-1 Trading Plan Policy | 13 | ||
Policies and Practices Related to the Grant of Certain Equity Awards Close in Time to the Release of Material Nonpublic Information | 13 | ||
Compensation Committee Interlocks and Insider Participation | 13 | ||
Family Relationships | 13 | ||
Delinquent Section 16(a) Reports | 13 | ||
PROPOSAL NO. 1 ELECTION OF DIRECTORS | 14 | ||
Directors Whose Terms Expire at the Annual Meeting | 14 | ||
Nominees | 14 | ||
Continuing Directors | 15 | ||
Director Compensation | 16 | ||
Required Vote | 17 | ||
PROPOSAL NO. 2 RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM | 18 | ||
Change in Independent Registered Public Accounting Firm | 18 | ||
Principal Accounting Fees and Services | 18 | ||
Audit Committee Policy on Pre-Approval of Audit and Permissible Non-Audit Services of Independent Registered Public Accounting Firm | 19 | ||
Required Vote | 19 | ||
REPORT OF THE AUDIT COMMITTEE | 20 | ||
EXECUTIVE OFFICERS | 21 | ||
EXECUTIVE COMPENSATION | 22 | ||
2025 Summary Compensation Table | 22 | ||
Salaries | 22 | ||
Equity Awards | 22 | ||
Equity Award Timing Policies and Practices | 23 | ||
Benefits | 23 | ||
Outstanding Equity Awards at Fiscal Year-End | 23 | ||
Executive Compensation Arrangements | 24 | ||
Potential Payments Upon Termination or Change in Control | 24 | ||
Compensation Recovery Policy | 26 | ||
Equity Compensation Plan Information | 27 | ||
Vayu 2022 Equity Incentive Plan | 27 | ||
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS | 29 | ||
CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS | 30 | ||
Related Party Transactions | 30 | ||
TABLE OF CONTENTS
Indemnification Agreements | 31 | ||
Policies and Procedures for Related Party Transactions | 31 | ||
WHERE YOU CAN FIND MORE INFORMATION | 33 | ||
HOUSEHOLDING OF ANNUAL MEETING MATERIALS | 33 | ||
ANNUAL REPORT | 33 | ||
Fiscal Year 2025 Annual Report and SEC Filings | 33 | ||
STOCKHOLDER PROPOSALS | 34 | ||
Stockholder Proposals for Inclusion in Proxy Statement (Rule 14a-8) | 34 | ||
Advance Notice Proposals and Director Nominations | 34 | ||
Universal Proxy Notice (Rule 14a-19) | 35 | ||
Availability of Bylaws | 35 | ||
OTHER MATTERS | 36 | ||
TABLE OF CONTENTS
TABLE OF CONTENTS
• | the election of two Class III directors, Ali Kashani and Touraj Parang, to serve until our 2029 annual meeting of stockholders and until their successors are duly elected and qualified; and |
• | the ratification of the appointment of PricewaterhouseCoopers LLP (“PwC”) as our independent registered public accounting firm for our fiscal year ending December 31, 2026. |
• | “FOR” the election of Ali Kashani and Touraj Parang as Class III directors; and |
• | “FOR” the ratification of the appointment of PwC as our independent registered public accounting firm for our fiscal year ending December 31, 2026. |
TABLE OF CONTENTS
TABLE OF CONTENTS
• | By Internet: You may submit a proxy over the internet by following the instructions at www.proxyvote.com, 24 hours a day, seven days a week, until 11:59 p.m. Eastern Time on June 16, 2026 (have your Notice or proxy card in hand when you visit the website); |
• | By Toll-Free Telephone: You may submit a proxy by calling 1-800-690-6903 24 hours a day, seven days a week, until 11:59 p.m. Eastern Time on June 16, 2026 (have your Notice or proxy card in hand when you call); or |
• | By Mail: You may complete, sign and mail your proxy card (if you received printed proxy materials) which must be received by us by 11:59 p.m. Eastern Time on June 16, 2026. |
TABLE OF CONTENTS
• | You may enter a new vote by internet or by telephone until 11:59 p.m. Eastern Time on June 16, 2026; |
• | You may submit another properly completed proxy card by mail with a later date, which must be received by us by 11:59 p.m. Eastern Time on June 16, 2026; or |
• | You may send written notice that you are revoking your proxy to Serve Robotics Inc., Attention: Corporate Secretary, 730 Broadway, Redwood City, CA 94063, which must be received by us by 11:59 p.m. Eastern Time on June 16, 2026. |
TABLE OF CONTENTS
Proposal | Votes Required | Effect of Abstentions | Effect of Broker Non-Votes | ||||||
Proposal 1: Election of Ali Kashani and Touraj Parang as Class III directors. | Plurality of the votes cast by the holders of shares of our common stock present by remote communication or represented by proxy at the Annual Meeting and entitled to vote. | No effect. | No effect. | ||||||
Proposal 2: Ratification of the appointment of PwC as our independent registered public accounting firm for our fiscal year ending December 31, 2026. | Affirmative vote of a majority of the votes cast by the holders of shares of our common stock present by remote communication or represented by proxy at the Annual Meeting and entitled to vote. | No effect. | No effect. | ||||||
Type of Submission | Applicable Rule | Deadline | ||||
Stockholder Proposals for Inclusion in Proxy Statement | Rule 14a-8 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) | No later than December 25, 2026 | ||||
Advance Notice Proposals and Director Nominations | Our amended and restated bylaws | No earlier than February 17, 2027 and no later than March 19, 2027 | ||||
Universal Proxy Notice | Rule 14a-19(b) under the Exchange Act | No later than April 18, 2027 | ||||
TABLE OF CONTENTS
TABLE OF CONTENTS
• | Establishing the agenda for regular meetings of our Board; |
• | Coordinating with the committee chairs regarding meeting agendas and information requirements and presiding over meetings of our Board; and |
• | Coordinating the activities of the other directors and performing such other duties as our Board may establish or delegate from time to time. |
TABLE OF CONTENTS
• | helping our Board oversee our corporate accounting and financial reporting processes; |
• | managing the selection, engagement, qualifications, independence, and performance of a qualified firm to serve as the independent registered public accounting firm to audit our financial statements; |
• | reviewing and discussing the scope and results of the audit with the independent registered public accounting firm, and reviewing, with management and our independent registered public accounting firm, our interim and year-end operating results; |
• | obtaining and reviewing a report by the independent registered public accounting firm at least annually that describes our internal quality control procedures, any material issues with such procedures and any steps taken to deal with such issues when required by applicable law; |
• | establishing procedures for employees to submit concerns anonymously about questionable accounting or audit matters; |
• | overseeing our policies on risk assessment and risk management; |
• | overseeing compliance with our Code of Business Conduct and Ethics; |
• | reviewing related person transactions; and |
• | approving or, as required, pre-approving audit and permissible non-audit services to be performed by the independent registered public accounting firm. |
TABLE OF CONTENTS
• | reviewing, approving and determining, or making recommendations to our Board regarding, the compensation of our Chief Executive Officer, other executive officers and senior management; |
• | reviewing and recommending to our Board the compensation paid to our non-employee directors; |
• | administering our equity incentive plans and other benefit programs; |
• | reviewing, adopting, amending and terminating incentive compensation and equity plans, severance agreements, profit sharing plans, bonus plans, change-of-control protections and any other compensatory arrangements for our executive officers and other senior management; and |
• | reviewing and establishing general policies relating to compensation and benefits of our employees, including our overall compensation philosophy. |
• | identifying and evaluating candidates, including the nomination of incumbent directors for reelection and nominees recommended by stockholders, to serve on our Board; |
• | considering and making recommendations to our Board regarding the composition and chairmanship of the committees of our Board; |
• | instituting plans or programs for the continuing education of our Board and the orientation of new directors; |
• | developing and making recommendations to our Board regarding corporate governance guidelines and matters; |
• | overseeing our corporate governance practices; |
• | overseeing periodic evaluations of our Board’s performance, including committees of our Board; and |
• | contributing to succession planning. |
TABLE OF CONTENTS
TABLE OF CONTENTS
• | engaging in short sales of the Company’s securities; |
• | trading in derivatives of the Company’s securities, such as exchange-traded put or call options and forward transactions; |
• | purchasing any financial instruments (such as prepaid variable forward contracts, equity swaps, collars or exchange funds) or otherwise engaging in any transactions that hedge or offset any decrease in the market value of the Company’s securities or limit the ability to profit from an increase in the market value of the Company’s securities; and |
• | holding the Company’s securities in a margin account or pledging the Company’s securities as collateral for a loan. |
TABLE OF CONTENTS
TABLE OF CONTENTS
Name | Class | Age | Position | Current Term Expires | Expiration of Term For Which Nominated | ||||||||||
Ali Kashani | III | 41 | Director | 2026 | 2029 | ||||||||||
Touraj Parang | III | 53 | Director | 2026 | 2029 | ||||||||||
TABLE OF CONTENTS
Name | Class | Age | Position | Current Term Expires | ||||||||
David Goldberg(1)(2) | I | 44 | Director | 2027 | ||||||||
Sarfraz Maredia | I | 43 | Director | 2027 | ||||||||
Lily Sarafan(1)(3) | II | 44 | Director | 2028 | ||||||||
Olivier Vincent(1)(3) | II | 62 | Director | 2028 | ||||||||
(1) | Member of the audit committee |
(2) | Member of the nominating and governance committee |
(3) | Member of the compensation committee |
TABLE OF CONTENTS
TABLE OF CONTENTS
Name | Fees earned or paid in cash ($) | Stock Awards ($)(1)(3)(4) | Option Awards ($)(2)(4) | Non-equity incentive plan compensation ($) | Nonqualified deferred compensation earnings ($) | All other compensation ($) | Total ($) | ||||||||||||||
David Goldberg | 30,000 | 205,200 | — | — | — | — | 235,200 | ||||||||||||||
Sarfraz Maredia | — | — | — | — | — | — | — | ||||||||||||||
Lily Sarafan | 30,000 | 205,200 | — | — | — | — | 235,200 | ||||||||||||||
Olivier Vincent | 30,000 | 205,200 | — | — | — | — | 235,200 | ||||||||||||||
(1) | Amounts reflected in this column represent the grant date fair value of restricted stock units. The grant date fair value is measured based on the closing price of our common stock on the date of grant in accordance with FASB ASC Topic 718. The valuation methodology and assumptions used in determining such amounts are described in Note 2 of the Company’s financial statements for the fiscal year ended December 31, 2025. |
(2) | Amounts reflected in this column represent the grant date fair value of options to purchase common stock computed in accordance with FASB ASC Topic 718. The valuation methodology and assumptions used in determining such amounts are described in Note 2 of the Company’s financial statements for the fiscal year ended December 31, 2025. |
(3) | The amount represents the grant date fair value of 20,000 restricted stock units granted on June 23, 2025, which is scheduled to vest in full on the earlier to occur of (i) the Company’s next annual stockholder meeting or (ii) June 12, 2026. |
(4) | The table below sets forth the number of outstanding and unvested equity awards held by each non-employee director as of December 31, 2025: |
Non-Employee Director | Number of Options Outstanding (#) | Number of RSUs Outstanding (#) | ||||
David Goldberg | — | 20,000 | ||||
Sarfraz Maredia | — | — | ||||
Lily Sarafan | — | 20,000 | ||||
Olivier Vincent | 12,000 | 20,000 | ||||
TABLE OF CONTENTS
2025 | 2024 | |||||
Audit Fees(1) | $1,375,238 | $302,928 | ||||
Audit-related Fees(2) | — | — | ||||
Tax Fees(3) | 87,000 | — | ||||
All Other Fees(4) | — | — | ||||
Total Fees | $1,462,238 | $302,928 | ||||
(1) | Audit fees consist of fees billed for professional services rendered by our independent registered public accounting firm for the audit of our annual consolidated financial statements and review of our interim condensed consolidated financial statements or services that are normally provided by our independent registered public accounting firm in connection with statutory and regulatory filings or engagements, which include services relating to business combinations. The fees for the audit services billed by PwC for the fiscal year ended December 31, 2025 amounted to $1,289,470. The fees for the audit services billed by dbbmckennon for the fiscal years ended December 31, 2025 and 2024 amounted to $85,768 and $302,928, respectively. |
(2) | Audit-related fees consist of assurance and related services that are reasonably related to the performance of audits or reviews of our financial statements and were not reported above under “Audit Fees.” There were no audit-related fees billed by PwC for the fiscal year ended December 31, 2025. There were no audit-related fees billed by dbbmckennon for the fiscal years ended December 31, 2025 and 2024. |
TABLE OF CONTENTS
(3) | Tax fees consist of fees billed for professional services rendered by our independent registered public accounting firm for tax compliance, tax advice, and tax planning. The fees for the tax services billed by PwC for the fiscal year ended December 31, 2025 amounted to $87,000. There were no tax fees billed by dbbmckennon for the fiscal years ended December 31, 2025 and 2024. |
(4) | All other fees consist of fees billed for all other services. There were no fees billed by PwC for other products and services for the fiscal year ended December 31, 2025. There were no fees billed by dbbmckennon for other products and services for the fiscal years ended December 31, 2025 and 2024. |
TABLE OF CONTENTS
TABLE OF CONTENTS
Name | Age | Position | ||||
Ali Kashani | 41 | Chief Executive Officer and Chairman of the Board | ||||
Touraj Parang | 53 | President, Chief Operating Officer and Director | ||||
Brian Read | 36 | Chief Financial Officer | ||||
TABLE OF CONTENTS
• | Ali Kashani: Chief Executive Officer |
• | Touraj Parang: President and Chief Operating Officer |
• | Brian Read: Chief Financial Officer |
Name and Principal Position | Year | Salary ($) | Bonus ($) | Stock Awards ($)(1) | Option Awards ($)(2) | Non-Equity Incentive Plan Compensation ($) | All Other Compensation ($) | Total ($) | ||||||||||||||||
Ali Kashani Chief Executive Officer | 2025 | 458,000 | — | 4,199,064 | — | — | — | 4,657,064 | ||||||||||||||||
2024 | 236,667 | — | 8,445,000 | — | — | — | 8,681,667 | |||||||||||||||||
Touraj Parang President and Chief Operating Officer | 2025 | 442,667 | — | 2,896,321 | — | — | — | 3,338,988 | ||||||||||||||||
2024 | 328,333 | — | 3,009,064 | — | — | — | 3,337,397 | |||||||||||||||||
Brian Read Chief Financial Officer | 2025 | 384,000 | — | 1,986,272 | — | — | — | 2,370,272 | ||||||||||||||||
2024 | 168,561 | 25,000 | 1,461,900 | — | — | — | 1,655,461 | |||||||||||||||||
(1) | Amounts reflected in this column represent the grant date fair value of restricted stock units. The grant date fair value is measured based on the closing price of our common stock on the date of grant in accordance with FASB ASC Topic 718. The valuation methodology and assumptions used in determining such amounts are described in Note 2 of the Company’s financial statements for the fiscal year ended December 31, 2025. |
(2) | Amounts reflected in this column represent the grant date fair value of options to purchase common stock computed in accordance with FASB ASC Topic 718. The valuation methodology and assumptions used in determining such amounts are described in Note 2 of the Company’s financial statements for the fiscal year ended December 31, 2025. |
TABLE OF CONTENTS
Option Awards(1) | Stock Awards(2) | |||||||||||||||||||||||||||||
Name | Grant Date | Number of securities underlying unexercised options exercisable (#) | Number of securities underlying unexercised options unexercisable (#) | Equity incentive plan awards: Number of securities underlying unexercised unearned options (#) | Option exercise price ($)(3) | Option expiration date ($) | Number of shares that have not vested (#) | Market value of shares that have not vested ($)(4) | Equity incentive plan awards: Number of unearned shares, units or other rights that have not vested (#) | Equity incentive plan awards: market or payout value of unearned shares, units or other rights that have not vested ($) | ||||||||||||||||||||
Ali Kashani | 6/7/2023(5) | 4,844 | 7,265 | — | 0.9447 | 6/6/2028 | — | — | — | — | ||||||||||||||||||||
4/27/2021 | — | — | — | — | — | 93,742(6) | 973,042 | — | — | |||||||||||||||||||||
9/5/2024 | — | — | — | — | — | 641,699(7) | 6,660,836 | — | — | |||||||||||||||||||||
7/22/2025 | — | — | — | — | — | 334,930(9) | 3,476,573 | — | — | |||||||||||||||||||||
Touraj Parang | 6/7/2023(5) | 2,288 | 3,170 | — | 0.8588 | 6/6/2033 | — | — | — | — | ||||||||||||||||||||
5/6/2021 | — | — | — | — | — | 33,448(6) | 347,190 | — | — | |||||||||||||||||||||
9/5/2024 | — | — | — | — | — | 230,429(7) | 2,391,853 | — | — | |||||||||||||||||||||
7/22/2025 | — | — | — | — | — | 231,020(9) | 2,397,988 | — | — | |||||||||||||||||||||
Brian Read | 4/3/2024 | — | — | — | — | — | 140,000(8) | 1,453,200 | — | — | ||||||||||||||||||||
9/5/2024 | — | — | — | — | — | 17,501(7) | 181,660 | — | — | |||||||||||||||||||||
7/22/2025 | — | — | — | — | — | 158,431(9) | 1,644,514 | — | — | |||||||||||||||||||||
(1) | All stock options above cover shares of our common stock granted under the 2021 Stock Plan. |
(2) | All restricted shares listed above for Mr. Kashani cover shares of our common stock granted outside of the 2021 Stock Plan, and all restricted shares listed above for Mr. Parang cover shares of our common stock granted under the 2021 Stock Plan. All restricted stock units above cover shares of our common stock granted under the 2023 Plan. |
TABLE OF CONTENTS
(3) | This column represents the fair market value of a share of our common stock on the date of grant, as determined by the Board. |
(4) | This column represents the total value of the number of unvested restricted shares outstanding as of December 31, 2025, multiplied by $10.38, which is the per share value of our common stock as of December 31, 2025. |
(5) | The options will vest as to 1/48th of the total number of option shares on July 1, 2023 and monthly thereafter. |
(6) | The restricted shares are subject to a 4-year vesting schedule running from the date the Board retroactively determined that vesting should run regardless of Milestone achievement, with 1/48th of the total number of shares vesting on July 15, 2022 and monthly thereafter. |
(7) | The restricted stock units will vest as to 1/3rd of the total number of shares on September 5, 2025 and 1/36th of the total number of shares monthly thereafter. |
(8) | The restricted stock units will vest as to 1/4th of the total number of shares on April 29, 2025 and 1/48th of the total number of shares monthly thereafter. |
(9) | The restricted stock units will vest as to 1/16th of the total number of shares on August 1, 2025 and quarterly thereafter. |
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
Plan Category | Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants and Rights (a) | Weighted Average Exercise Price of Outstanding Options (b)(1) | Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding Securities Reflected in Column (a)) (c) | ||||||
Equity compensation plans approved by security holders | 7,745,263(2) | $0.85 | 3,187,066(3) | ||||||
Equity compensation plans not approved by security holders | 81,579(4) | 4.85 | 91,835(5) | ||||||
Total | 7,826,842 | $0.89 | 3,278,901 | ||||||
(1) | The weighted-average exercise price does not include outstanding restricted stock or restricted stock units, which have no exercise price. |
(2) | As of December 31, 2025, total number of securities (column (a)) consists of (i) 743,215 shares of common stock issuable upon exercise of options, (ii) 137,743 of restricted stock awards and (iii) 6,864,305 of shares of common stock issuable upon vesting of outstanding restricted stock units (including 100,000 performance-based restricted stock units, assuming target performance) granted under the Serve Robotics Inc. 2021 Stock Plan and under the Serve Robotics Inc. 2023 Equity Incentive Plan (“2023 Plan”). |
(3) | Includes 3,187,066 shares of our common stock available for issuance under the 2023 Plan. The number of shares available for issuance under the 2023 Plan may, at the discretion of the Board or a committee thereof, be increased on October 1st of each fiscal year beginning with the 2023 fiscal year until the 2023 Plan terminates, in each case, in an amount equal to the lesser of (i) at the discretion of our Board, 4% of the shares of common stock issued and outstanding on the last day of the immediately preceding month on a fully-diluted and as-converted basis and (ii) such other number of shares determined by our Board. |
(4) | Represents 81,579 shares of common stock issuable upon exercise of options assumed by us in connection with the acquisition of Vayu Robotics, Inc. (“Vayu”) as of December 31, 2025. As of December 31, 2025, a total of 1,225,262 shares of common stock were issuable upon vesting of outstanding restricted stock units (including 801,292 performance-based restricted stock units, assuming target performance) assumed by us in connection with the acquisition of Vayu (in addition to the 81,579 shares of common stock that were issuable upon exercise of options assumed by us in connection with the acquisition of Vayu as of December 31, 2025). In connection with the acquisition of Vayu, we have assumed outstanding stock options and rights granted pursuant to the Vayu 2022 Equity Incentive Plan (the “2022 Vayu Plan”), outstanding restricted stock units granted pursuant to the Vayu 2025 Equity Incentive Plan (the “Vayu 2025 Plan”), and the Vayu 2022 Plan, but we did not assume the Vayu 2025 Plan itself. Therefore, no further stock options or other awards may be granted under the Vayu 2025 Plan, but further stock options or other awards may be granted under the Vayu 2022 Plan. |
(5) | Represents 91,835 shares issuable for future grant under the 2022 Vayu Plan (assumed in connection with the acquisition of Vayu) as of December 31, 2025. The weighted average exercise price of those outstanding options is $4.85 per share as of December 31, 2025. |
TABLE OF CONTENTS
TABLE OF CONTENTS
• | each person or group of affiliated persons known by us to be the beneficial owner of more than 5% of our common stock; |
• | each of our named executive officers; |
• | each of our directors and nominees for director; and |
• | all of our current executive officers and directors as a group. |
Name of Beneficial Owner | Number of Shares Beneficially Owned | Percentage of Shares Beneficially Owned | ||||
5% Stockholders | ||||||
Vinod Khosla(1) | 4,801,324 | 5.9% | ||||
Directors, Director Nominees and Named Executive Officers | ||||||
Ali Kashani(2) | 2,686,653 | 3.5% | ||||
Touraj Parang(3) | 953,080 | 1.2% | ||||
Brian Read(4) | 59,438 | * | ||||
David Goldberg(5) | 45,725 | * | ||||
Lily Sarafan(6) | 58,402 | * | ||||
Olivier Vincent(7) | 41,928 | * | ||||
Sarfraz Maredia | — | — | ||||
All directors, director nominees and executive officers as a group (seven persons) | 3,845,226 | 5.0% | ||||
* | Represents beneficial ownership of less than one percent (1%) of the outstanding shares of our common stock. |
(1) | Consists of (i) 49,871 shares of common stock held by Khosla Ventures Seed D, LP, (ii) 672,834 shares of common stock held by Khosla Ventures Seed E, LP, (iii) 78,619 shares of common stock held by Khosla Ventures VI, LP, and (iv) 4,000,000 shares underlying warrants to purchase common stock held by Khosla Ventures Seed E, LP which are exercisable within 60 days of April 20, 2026. Vinod Khosla is the managing member of VK Services, LLC (together with Khosla Ventures Seed D, LP, Khosla Ventures Seed E, LP, Khosla Ventures VI, LP and Vinod Khosla, collectively the “KV Reporting Persons”), which is the sole manager of each of (i) Khosla Ventures Seed Associates D, LLC, which is the general partner of Khosla Ventures Seed D, LP, (ii) Khosla Ventures Seed Associates E, LLC, which is the general partner of Khosla Ventures Seed E, LP and (iii) Khosla Ventures Associates VI, LLC, which is the general partner of Khosla Ventures VI, LP. The address of each of the KV Reporting Persons is 2128 Sand Hill Road, Menlo Park, CA 94025. The foregoing information is based on a Schedule 13G reflecting beneficial ownership of the Company’s common stock filed with the SEC on September 15, 2025. |
(2) | Consists of (i) 2,458,647 shares of common stock held directly by Ali Kashani, (ii) 16,070 shares of common stock held by Nikki Stoddart, the spouse of Dr. Kashani, (iii) 80,350 shares of common stock held by Salma Kashani, (iv) 8,035 shares of common stock held by Ali Sadeghi Hariri, (v) 7,265 shares of common stock underlying options which are or will become exercisable within 60 days of April 20, 2026 and (vi) 116,286 shares of restricted stock units which will become vested within 60 days of April 20, 2026. Dr. Kashani may be deemed to share beneficial ownership over the shares of common stock held by Ms. Stoddart. |
(3) | Consists of (i) 900,138 shares of common stock, (ii) 3,345 shares of common stock underlying options which are or will become exercisable within 60 days of April 20, 2026, and (iii) 49,597 shares underlying restricted stock units which will become vested within 60 days of April 20, 2026. |
(4) | Consists of (i) 36,454 shares of common stock and (ii) 22,984 shares underlying restricted stock units which will become vested within 60 days of April 20, 2026. |
(5) | Consists of (i) 25,725 shares of common stock and (ii) 20,000 shares underlying restricted stock units which will become vested within 60 days of April 20, 2026. |
(6) | Consists of (i) 38,402 shares of common stock and (ii) 20,000 shares underlying restricted stock units which will become vested within 60 days of April 20, 2026. |
(7) | Consists of (i) 9,928 shares of common stock, (ii) 20,000 shares underlying restricted stock units which will become vested within 60 days of April 20, 2026 and (iii) 12,000 shares of common stock underlying options which are or will become exercisable within 60 days of April 20, 2026. |
TABLE OF CONTENTS
TABLE OF CONTENTS
Purchaser | Shares of Common Stock Purchased | Aggregate Purchase Price | ||||
Postmates, LLC | 1,125,000 | $4,500,000 | ||||
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
Type of Submission | Applicable Rule | Deadline | ||||
Stockholder Proposals for Inclusion in Proxy Statement | Rule 14a-8 under the Exchange Act | No later than December 25, 2026 | ||||
Advance Notice Proposals and Director Nominations | Our amended and restated bylaws | No earlier than February 17, 2027 and no later than March 19, 2027 | ||||
Universal Proxy Notice | Rule 14a-19(b) under the Exchange Act | No later than April 18, 2027 | ||||
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS

TABLE OF CONTENTS
